ClinicalTrials.Veeva

Menu

Study of a Nutritional Supplement for Healthy Aging (ACTIPRO SENIOR)

U

University of Navarra

Status

Completed

Conditions

Quality of Life
Nutrition, Healthy

Treatments

Dietary Supplement: Control supplement
Dietary Supplement: Nutritional supplement

Study type

Interventional

Funder types

Other

Identifiers

NCT06743841
ACTIPRO SENIOR (2021.116)

Details and patient eligibility

About

The main aim of this clinical trial is to learn if a nutritional supplement improves health status from a nutritional point of view in an active and healthy elderly population. It will also study about the improvement of anthropometric variables, vitality, quality of life and mood, as well as biochemical and metabolic changes produced after the intervention.

The main questions it aims to answer are:

  • Does a nutritional supplement improve the general nutritional status?
  • What health parameters improve most clearly after taking the supplement? Researchers will compare a nutritional supplement to a placebo (a look-alike substance that contains no interest nutrients) to see if the nutritional supplement works to improve health status from a nutritional point of view.

Participants will:

  • Take a nutritional supplement or a placebo every day for 8 weeks.
  • Visit the clinic once every 4 weeks for checkups and tests
  • Keep a diary of their symptoms and the degree of adherence to taking the nutritional supplement.

Enrollment

60 patients

Sex

All

Ages

65 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Men and women between 65 and 80 years of age, inclusive.
  • Body mass index (BMI) less than 35 kg/m2.
  • Subjects must have a cultural level, general physical and psychological conditions that allow the understanding, monitoring and development of the study.
  • Agree to voluntarily participate in the study and provide their informed consent in writing, complying with the procedures and requirements of the study.

Exclusion criteria

  • People allergic to soy or lactose, as the supplement contains traces.
  • Severe diseases or relevant functional or structural abnormalities of the digestive system: inflammatory bowel disease.
  • Surgical interventions of the digestive system with permanent sequelae such as resections (gastroduodenostomy...)
  • Presenting any type of serious or chronic or systemic disease such as: infections that cause impairment of the general condition, cardiovascular diseases, cardiac arrhythmias, stroke, neoplasia, severe kidney disease, liver disease...
  • Recent fracture in the last 3 months (strength training).
  • Subjects who present some type of cognitive and/or psychological impediment, Alzheimer's, depressive pathology, etc.
  • Pharmacological treatment that affects the study variables recently prescribed, without a stable dose prescribed.
  • People with diabetes of any type.
  • Intake of any type of nutritional supplement that includes vitamin D, folic acid, vitamin B6, vitamin B12, calcium, iron, zinc or proteins, in the last 3 months.
  • Being on any type of special diet and/or high alcohol consumption (more than 14 units in women and 20 units in men per week).
  • Subjects in whom poor collaboration is expected or who, in the opinion of the researcher, have difficulties in following the procedures of the study.
  • Lack of commitment (in the opinion of the researcher) to the intervention, suspicion of non-compliance, or real difficulties in following the development of the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups, including a placebo group

Nutritional Supplement
Experimental group
Description:
1 sachet of nutritional supplement (30g) in the morning and 1 sachet (30g) in the afternoon during 8 weeks. A total of 60g daily.
Treatment:
Dietary Supplement: Nutritional supplement
Control
Placebo Comparator group
Description:
1 sachet of placebo supplement (30g) in the morning and 1 sachet (30g) in the afternoon during 8 weeks. A total of 60g daily.
Treatment:
Dietary Supplement: Control supplement

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems